Lactulose, L-ornithine L-aspartate, or Rifaximin Versus Placebo for Preventing Hepatic Encephalopathy in Variceal Bleeding
Status:
Completed
Trial end date:
2016-06-01
Target enrollment:
Participant gender:
Summary
The aim of this study is to determine whether lactulose, L-ornithine L-aspartate, and
rifaximin are effective in the prevention of the development of hepatic encephalopathy in
cirrhotic patients with acute variceal bleeding